NCT05947383View on ClinicalTrials.gov

Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

February 1, 2026

Conditions
CancerMajor Depressive Disorder
Interventions
DRUG

Psilocybin

Psilocybin 25 mg oral capsule

DRUG

Placebo

Niacin 100 mg oral capsule

Trial Locations (1)

20850

RECRUITING

Sunstone Medical, PC, Rockville

All Listed Sponsors
lead

Sunstone Medical

OTHER